首页> 美国卫生研究院文献>Toxicological Research >Study of a BALB/c Mouse Model for Allergic Asthma
【2h】

Study of a BALB/c Mouse Model for Allergic Asthma

机译:BALB / c小鼠过敏性哮喘的模型研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Allergic asthma is a worldwide public health problem and a major socioeconomic burden disease. It is a chronic inflammatory disease marked by airway eosinophilia and goblet cell hyperplasia with mucus hypersecretion. Mouse models have proven as a valuable tool for studying human asthma. In the present report we describe a comparison of mouse asthma models. The experiments were designed as follows: Group I was injected with ovalbumin (OVA, i.p.) on day 1 and challenged with 1% OVA (aerosol exposure) on days 14~21. Group II was injected on day 1, 14 and aerosol-immunized on days 14~21. Group III was injected on day 1, 14 and immunized by 1% OVA aerosol on days 18~21. We assessed asthma induction by determining the total number of white blood cells (WBC) and eosinophils as well as by measuring cytokine levels in bronchoalveolar lavage fluid (BALF). In addition, we evaluated the histopathological changes of the lungs and determined the concentration of immunoglobulin E (IgE) in serum. Total WBC, eosinophils, Th2 cytokines (IL-4, IL-13) and IgE were significantly increased in group I relative to the other groups. Moreover, histopathological studies show that group I mice show an increase in the infiltration of inflammatory cell-in peribronchial and perivascular areas as well as an overall increase in the number of mucus-containing goblet cells relative to other groups. These data suggest that group I can be a useful model for the study of human asthma pathobiology and the evaluation of existing and novel therapeutic agents.
机译:过敏性哮喘是世界范围内的公共卫生问题,是主要的社会经济负担疾病。它是一种慢性炎症性疾病,以气道嗜酸性粒细胞增多和杯状细胞增生伴有粘液分泌过多为特征。小鼠模型已被证明是研究人类哮喘的重要工具。在本报告中,我们描述了小鼠哮喘模型的比较。实验设计如下:第一组在第1天注射卵清蛋白(OVA,i.p.),并在第14-21天注射1%OVA(气雾剂暴露)攻击。第II组在第1、14天注射,并在第14-21天进行气雾免疫。第III组在第1、14天注射,并在18-21天用1%OVA气雾剂免疫。我们通过确定白细胞(WBC)和嗜酸性粒细胞的总数以及通过测量支气管肺泡灌洗液(BALF)中的细胞因子水平来评估哮喘的诱导。此外,我们评估了肺的组织病理学变化,并确定了血清中免疫球蛋白E(IgE)的浓度。与其他组相比,第一组的总白细胞,嗜酸性粒细胞,Th2细胞因子(IL-4,IL-13)和IgE显着增加。此外,组织病理学研究显示,与其他组相比,I组小鼠在支气管周围和血管周围区域中炎性细胞的浸润增加,而含黏液的杯状细胞总数总体增加。这些数据表明,I组可以成为研究人类哮喘病理生物学和评估现有和新型治疗药物的有用模型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号